Editor's Note Preoperative use of GLP-1 receptor agonists (RA) medications such as Ozempic and Wegovy is safe, according to a study published in the June issue of the American Journal of Gastroenterology. Controversy has swirled around these drugs due to the risk of slowed stomach emptying increasing a patient’s odds…

Read More

Editor's Note Researchers claim a stem cell transplant cured type 2 diabetes in a 59-year-old man who previously needed multiple daily insulin injections, the South China Morning Post reported May 27. The Chinese researchers behind the reported breakthrough published details of the case April 30 in the journal Cell Discovery.…

Read More

Editor's Note A study published May 7 in JAMA Open found no significant risk of periprosthetic joint infection (PJI) when colonoscopy is performed within one year of total joint arthroplasty (TJA), whether the colonoscopy was done before or after the surgery. However, certain comorbidities such as kidney and pulmonary disease,…

Read More

Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…

Read More

Editor's Note Popular weight-loss \ drug semaglutide could significantly increase risk for repeat operations patients with diabetes who undergo lumbar surgery. According to a May 8 report in Medscape Medical News, the findings are pending review for publication and reportedly provides the first evidence on the impact of semaglutide on…

Read More

Editor's Note Recent research suggests that minimizing the risk of perioperative pulmonary aspiration in diabetic patients does not require different fasting instructions. However, at least one expert has questioned the results, and widespread glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of both type 2 diabetes and weight loss can…

Read More

Editor's Note Laparoscopic sleeve gastrectomy improves eligibility for kidney transplants in patients with obesity as well as advanced chronic kidney disease, according to a Mayo Clinic study. According to a May 2 report on the results, the surgical weight-loss procedure also reduces the risk of cardiovascular conditions, such as diabetes…

Read More

Editor's Note Gastrointestinal endoscopy could increase the risk of aspirational pneumonia in patients using GLP-1 receptor agonists (RAs) to manage weight or treat diabetes, according to an April 1 report from MedPage today. Citing research published in the journal Gastroenterology by a team led by Kevin Sheng-Kai Ma, DDS, of…

Read More

Editor's Note A paper published March 29 in the journal Bioengineering examines the growing integration of artificial intelligence (AI) into hospital and healthcare systems and the way in which it is augmenting clinical decision-making, optimizing hospital operation and management, improving medical image analysis, and transforming patient care and monitoring through…

Read More

Editor's Note Bariatric surgery is more effective than lifestyle and medical interventions in glycemic control for Type 2 diabetes patients, according to findings published February 27 in JAMA. The clinical trial involved four health systems and 262 participants, 96 of whom received medical- and lifestyle-focused treatment and 166 of whom…

Read More